Detalles de la búsqueda
1.
Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
Circulation
; 144(22): 1750-1759, 2021 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34706555
2.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Circulation
; 144(23): 1845-1855, 2021 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34710343
3.
Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses.
Circulation
; 143(1): 33-44, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33148016
4.
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
N Engl J Med
; 380(1): 11-22, 2019 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30415628
5.
EPA and DHA containing phospholipids have contrasting effects on membrane structure.
J Lipid Res
; 62: 100106, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34400132
6.
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
Circulation
; 141(5): 367-375, 2020 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31707829
7.
Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies.
Eur Heart J Suppl
; 22(Suppl J): J34-J48, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33061866
8.
Response by Bhatt et al to Letter Regarding Article, "REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States".
Circulation
; 141(21): e834-e835, 2020 05 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32453660
9.
Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies.
Prostaglandins Other Lipid Mediat
; 125: 57-64, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27418543
10.
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.
J Am Heart Assoc
; 12(5): e026756, 2023 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36802845
11.
Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE-IT.
J Am Heart Assoc
; 11(7): e024999, 2022 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35377160
12.
Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
J Am Coll Cardiol
; 79(17): 1660-1671, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35483753
13.
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCI.
J Am Heart Assoc
; 11(6): e022937, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35261279
14.
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
J Am Coll Cardiol
; 78(15): 1525-1537, 2021 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34620410
15.
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19.
iScience
; 24(9): 103040, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34462732
16.
Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitro.
Biochim Biophys Acta Biomembr
; 1862(7): 183254, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32135144
17.
Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study.
Cardiol Ther
; 8(1): 79-90, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30788718
18.
Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study).
Am J Cardiol
; 124(5): 696-701, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31277790
19.
Icosapent ethyl reduces atherogenic markers in high-risk statin-treated patients with stage 3 chronic kidney disease and high triglycerides.
Postgrad Med
; 131(6): 390-396, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31306043
20.
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT.
J Am Coll Cardiol
; 73(22): 2791-2802, 2019 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30898607